Barbara S. Wiggins, Pharm.D., BCPS, CLS, FNLA, FAHA
Reportable Conflicts of Interests: Speaker: Pfizer. Speaker: Merck-Shering Plough.
Disclosure of Financial Conflicts of Interest: None
Education:
Doctor of Pharmacy
Virginia Common Wealth University
School of Pharmacy
Medical College of Virginia
Bachelor of Science in Pharmacy
St. Louis College of Pharmacy
St. Louis, Missouri
Post Graduate or Residency Training:
Clinical Research Fellowship (completed 1 year of 2)
Cardiology/Emergency Medicine
Virginia Commonwealth University
Medical College of Virginia
Richmond Virginia
Fellowship and Board Certifications:
Clinical Lipid Specialist
Board Certified Pharmacotherapy Specialist
Added qualifications in Cardiology
Advanced Cardiac Life Support
Advanced Cardiac Life Support Instructor
Basic Life Support
Current Position or Practice Site:
Clinical Assistant Professor
Department on Internal Medicine
Division of Cardiology
University of Virginia School of Medicine
Charlottesville, VA
Clinical Assistant Professor
Department of Pharmacy
Virginia Commonwealth University/Medical College of Virginia
School of Pharmacy
Richmond, VA
Pharmacy Clinical Specialist – Cardiology
University of Virginia Health System
Heart Center
Charlottesville, VA
Clinical Instructor
University of Virginia School of Nursing
Charlottesville, VA
Past Positions and/or Appointments:
Clinical Instructor in Cardiology 2003-2005
University of Virginia School of Medicine
Charlottesville, VA
Clinical Pharmacist – Cardiology 1999-2002
University of Washington Medical Center
Seattle, WA
Clinical Instructor 1999-2002
University of Washington School of Pharmacy
Seattle, WA
Clinical Research Fellow – Cardiology/Emergency Medicine 1998-1999
Virginia Commonwealth University
Medical College of Virginia Campus
Richmond, VA
United States Navy 1998-1999
Pharmacy Department Head
Naval Medical Clinic
Quantico, VA
United States Navy 1998-1999
Division Officer
Scott Center Pharmacy
Portsmouth, VA
United States Navy 1993-1995
Division Officer
Outpatient Pharmacy Department
Naval Medical Center Portsmouth
Portsmouth, VA
Pharmaceutical Sales Representative 1992-1993
Eli Lilly & Company
Indianapolis, IN
Professional Memberships:
American College of Cardiology- Cardiac Care Association
Diplomate with Accreditation Council for Clinical Lipidology
National Lipid Association
Virginia Society of Health System Pharmacists
Washington State Society of Health-System Pharmacists
American Heart Association
American College of Clinical Pharmacy
American Society of Health Systems Pharmacists
Publications:
Jackevicius C, Page RL, Chow S, Dunn SP, Lee CR, Ng T, Rodgers JE, Vardeny O, Wiggins BS, Munger M. High-Impact Articles Related to the Management of Heart Failure: Update 2008. Pharmacotherapy 2008. In Press.
Klepser ME, Matzke GR, Vivian E, Granberry M, Majerus T, Wiggins BS, Hill-Zalala C, Weimert N, Raebel MA. ACCP White Paper. Ethical Issues Related to Clinical, Translational, and Health System Research. Pharmacotherapy. 2008;(28):10:229e-243e.
Dobesh PP, Brouse SD, Dager WE, Spinler SA, Stacy Z, Wiggins BS. Key Articles and Guidelines in the Management of Acute Coronary Syndrome and in Percutaneous Coronary Intervention. 2007 Update. Pharmacotherapy. 2007;27(12):1722-1758.
Buck ML, Wiggins BS, Sesler JM. Intraosseous Administration of Drugs in Children and Adults during Cardiopulmonary Resuscitation. Ann Pharmacother. 2007. Oct;41(10):1679-86.
Wiggins, BS. Clinical Perspective on the use of Antithrombotic Agents in Acute Coronary Syndromes. Newsletter for Princeton CME. 2006.
Dager, W., Sanoski C., Wiggins BS., Tisdale J. Pharmacologic Therapy in ACLS: A review and update of the guidelines. Pharmacotherapy. 2006(26):12;1703-1729.
Levine GN, Berger PB, Cohen DJ, Maree AO, Rosendfield K, Wiggins BS, Spinler SA. Newer Pharmacotherapies in Patients Undergoing Percutaneous Coronary Interventions. A Guide for Pharmacists and Other Health Care Professionals. Expert Opinion from the American Heart Association’s Diagnostic and Interventional Catheterization Committee and Council on Clinical Cardiology, and the American College of Clinical Pharmacy’s Cardiology Practice Research Network. Pharmacotherapy. 2006;26(11):1537-1556.
CW Holtzman, Wiggins BS, Spinler SA. The role of P-glycoprotein in statin drug interactions. Pharmacotherapy. 2006;26(11):1601-1607.
Wiggins BS, Beavers MB. P-Glycoprotein can interact with cardiovascular drugs. Today in Cardiology. MAY 2005;(8)5:25.
Wiggins BS. Spinler S. Antiplatelet and antithrombin therapy for early management of acute coronary syndromes: J Pharm Pract. 2004:17;5:347-369.
Ng, TN, Carter O, Guillory GS, Howard PA, Lee CR, Rodgers JE, Uber PA, Wiggins BS, Munger MA, Patterson JH. High impact articles related to the pharmacotherapeutic management of systolic heart failure. Pharmacotherapy. 2004. November 24(11):1594-1633.
Wiggins BS. Aldosterone antagonists: Select patients carefully, monitor closely. Pharmacology Consult. Today in Cardiology. 2004 February;12.
Wiggins BS, Spinler S, Wittkowsky AK, Stringer KA. Bivalirudin: A direct thrombin inhibitor for percutaneous transluminal coronary Angioplasty. Pharmacotherapy. 2002 Aug. 22(8):1007-1018.
Wiggins BS. Pharmacology Consult: Warfarin has multiple herbal drug interactions. In Today in Cardiology. 2002;May 5(5):28.
Kondo LM, Wittkowsky AK, Wiggins BS. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
Ann Pharmacother. 2001 Apr;35(4):440-51. Review.
Wiggins BS, Wittkowsky AK, Nappi JM. Clinical use of new antithrombotic therapies for medical management of acute coronary syndromes. Pharmacotherapy. 2001 Mar;21(3):320-37. Review.
Wiggins BS. The management of hypercholesterolemia revisited. Manage Care Interface. 2001 Jan;14(1):58-66,72.
Kannewurf BS, Gonzalez ER. Ventricular Tachycardia/Ventricular Fibrillation; Basic Bibliographies. Hospital Pharmacy. 1999;34(3):381.
Kannewurf BS. A Possible New Standard of Care for Prehospital Cardiac Arrest. The Pharmacist Reporter. American Society of Health-System Pharmacists-33rd Midyear Clinical Meeting. 4(5):61-66. 1999.
Gonzalez ER, Kannewurf BS. Intermittent Inotropic Infusion Therapy. U.S. Pharmacist – Health Systems Edition. 1998:HS37-HS48.
Gonzalez ER, Kannewurf BS. Assessing the Value and Affordability of Cholesterol Reduction in the Managed Care Setting. Amer J Mang Care. 1998;4(4 Suppl):S226- S233.
Gonzalez ER, Kannewurf BS. Atherosclerosis – A Unifying Disorder With Various Manifestations. Amer J Hosp Pharm. 1998;55(Suppl 1):S4-S7.
Gonzalez ER, Kannewurf BS, Ornato JP. Intravenous Amiodarone for Ventricular Arrhythmias: Overview and Clinical Use. Resuscitation.1998;39:33-42.
Gonzalez ER, Kannewurf BS. Clinical Review of Appropriate Uses for Albumin. U.S Pharmacist- Health Systems Edition.1998;23(12):HS15-HS26.
Books and/or Chapters:
Wiggins BS, Saseen JJ, Spinler SA. Eds. Pharmacist’s Guide to Lipid Management. 1st ed. Lenexa, Kansas. American College of Clinical Pharmacy. 2008.
Wiggins BS. Dyslipidemia. In: Crouch MA, Editor. Cardiovascular Pharmacotherapy: a point-of-care guide. 1st ed. Bethesda, Maryland. American Society of Health-System Pharmacists. In progress.
McKenney JM, Ganz P, Wiggins BS, Saseen J. Statins. In: Clinical Lipidology: A Companion to Braunwald’s Heart Disease. Ballantyne C, ed. Elsevier 2008.
Wiggins BS. Pharmacotherapy. In: Pharmacists Guide to Lipid Management. Wiggins BS, Saseen JJ, Spinler SA., eds. 1st ed. Lenexa, Kansas. American College of Clinical Pharmacy. Lenexa, KS. 2008.
Wiggins BS. Pharmacology. In: Medicine Recall. Bergin JD Ed. 3rd Edition. Wolters Kluwer/Lippincott Williams & Wilkins Pub. 2008.
Wiggins BS. Pharmacology. In: Advanced Medicine Recall. Bergin JD. Ed. 3rd Edition. Wolters Kluwer/Lippincott Williams & Wilkins Pub. 2008.
Wiggins BS, Rodgers JE. Chronic Heart Failure Management. In: Pharmacotherapy Self- Assessment Program (PSAP). 6th Ed. 2007.
Gonzalez ER, Kannewurf BS, Hess ML. Inotropic Therapy and The Critically Ill Patient In: Textbook of Critical Care. Eds: Shoemaker, Ayers, Grenick, Holbrook, W. B. Saunders. 2000.
Gonzalez ER, Kannewurf BS. Acute Myocardial Infarction In: Textbook of Therapeutics; Drug and Disease Management. Eds: Gourley, Hurfindal. 7th Ed. 2001.
Presentations (National, State and Local):
Clinical Peals. Iodine and Shellfish Allergy – Does Contrast Exposure Pose a Risk?
Virginia Society of Health System Pharmacists. Wintergreen, Virginia. October 2008.
Safe Prescribing of Lipid Lowering Therapy. Virginia Chapter of The American College of Cardiology, CNA Education Day. Richmond, Virginia. October, 2008.
What’s New in Cardiovascular Pharmacology. Virginia Chapter of The American College of Cardiology, CNA Education Day. Richmond, Virginia. October, 2008.
Residual Risk and the Role of HDL-C and Triglycerides in the Prevention of Cardiovascular Disease. Preventive Cardiovascular Nurse Association. Charlottesville, Virginia. September 2008.
Pharmacologic Therapies and Treatment Guidelines. Southeast Lipid Association 11th Annual Scientific Forum for the Lipid Management Training Course. Hilton Head, SC August 2008.
3 Adherence Strategies that Work. Southeast Lipid Association 11th Annual Scientific Forum for the Lipid Management Training Course. Hilton Head, SC. August 2008
Pharmacologic Therapies and Treatment Guidelines. Southeast Lipid Association 10th Annual Scientific Forum for the Lipid Management Training Course. Savannah, GA. August 2007
Barriers to Therapy Adherence and Safety. Southeast Lipid Association 10th Annual Scientific Forum for Masters in Lipidology Course. Savannah, GA. August 2007.
Adherence/Compliance with Guidelines: Are We Meeting Our Patients Needs. Workshop for Southeast Lipid Association 10th Annual Scientific Forum. Savannah, GA. August 2007.
Getting to Goal – Treatment Options for Achievement of LDL-C Reduction. A Princeton Teleconference Series. June 2007.
Special Populations and Challenging Patients – A Case Study Approach. Masters in Lipidology Course. Montreal, Canada. April 2007.
Evidence-based Strategies for the Management of Dyslipidemia: A Case Study Approach. American Society of Health System Pharmacists – Mid-year Clinical Meeting. Anaheim, CA 2006.
The CAD epidemic- Pathogenesis and Overview of Statin Use. Winchester Medical Center, Dinner Program. Winchester, Virginia. November 2006.
Coronary Artery Disease – Overview of the Guidelines and Management. Winchester Medical Center Department of Pharmacy, Virginia. November 2006.
Update on the use of statins in the Management of Coronary Artery Disease. Virginia Society of Health-System Pharmacists – Fall Seminar – Norfolk, Virginia. October 2006.
Update in Advanced Cardiac Life Support (ACLS): A review of the new guidelines. Pharmacy Grand Rounds. University of Virginia Health System. February 2006.
Cardiovascular Diagnostic Measures: Cardiovascular Pre-Meeting Symposium. American College of Clinical Pharmacy Annual Meeting. San Francisco, California 2005
Update in Advanced Cardiac Life Support (ACLS). Pharmacy Grand Rounds. University of Virginia Health System. March 2004.
Pharmacologic Management of Primary Pulmonary Hypertension. Virginia Society of Health-System Pharmacists, Williamsburg, Virginia. March 2003.
Management of Congestive Heart Failure in the Elderly. Washington State Pharmacy Association Spring Continuing Education Meeting. Seattle, WA. March 9th, 2002.
New Laws New Drugs 2002 Cardiovascular Update. Continuing Pharmacy Education. Washington State Pharmacy Association. Seattle, WA. January 2002.
Recent Advances in Treatment of Acute Decompensated Heart Failure.
Medicine Grand Rounds. Southwest Washington Medical Center. Vancouver, Washington. 2002.
Natriuretic Peptides - A New Therapeutic Compound for the Treatment of Acute Decompensated CHF. Pyramid Breweries. Seattle, WA. October 10th, 2001.
A New Treatment Strategy for the Acute CHF Patient. The Vault Restaurant. Tacoma, WA. September 25th, 2001.
Nesiritide for the Management of Acute Congestive Heart Failure. Kitsap County Cardiology. Molly. Bremerton, WA. September 19th, 2001.
Pharmacological Management of Congestive Heart Failure in the Elderly. Geriatric Drug Therapy Conference. University of Washington School of Nursing. Continuing Nursing Education. April 2000
Changing the Pharmacotherapy of Ventricular Tachycardia/Ventricular Fibrillation: Medical Legal Implications. American Society of Health Systems Pharmacists Midyear Clinical Meeting. Las Vegas Nevada, December, 1998.
New Approaches to Treating Ventricular Tachycardia and Ventricular Fibrillation in the Pre-Hospital Setting. American College of Clinical Pharmacy Annual Meeting, Cincinnati, Ohio, November, 1998
Congestive Heart Failure. Continuing Medical Education. American Society of Health Systems Pharmacists- Federal Pharmacists Forum, ASHP Midyear Clinical Meeting, Atlanta, Georgia, December, 1997.
Congestive Heart Failure. New Therapies and Misconceptions. A Case Presentation. Pharm. D. Candidates. Medical College of Virginia/Virginia Commonwealth University, Richmond, Virginia, November 1997.
Treatment of Septic Shock. A Case Presentation. Doctor of Pharmacy Candidates. Medical College of Virginia/Virginia Commonwealth University, September 1997.
(Last updated: 2/9/2009)
